A Randomised controlled feasibility trial comparing the clinical and cost effectiveness of cognitive behavioural therapy (CBT) and selective serotonin reuptake inhibitors (SSRI) and their combination in the management of obsessive compulsive disorder (OTO Trial)

Barton, Garry (Principal Investigator)
Fineberg, Naomi (Principal Investigator)
Pond, Martin (CTU Role)

Hertfordshire Partnership NHS Foundation Trust

Status	Finished
Effective start/end date	1/04/14 → 31/07/17

Funding

National Institute for Health and Care Research: £13,870.00

1 Article

Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder
Fineberg, N. A., Baldwin, D. S., Drummond, L. M., Wyatt, S., Hanson, J., Gopi, S., Kaur, S., Reid, J., Marwah, V., Sachdev, R. A., Pampaloni, I., Shahper, S., Varlakova, Y., Mpavaenda, D., Manson, C., O’Leary, C., Irvine, K., Monji-Patel, D., Shodunke, A., Dyer, T., & 3 othersDymond, A., Barton, G. & Wellsted, D., 1 Nov 2018, In: International Clinical Psychopharmacology. 33, 6, p. 334–348
Research output: Contribution to journal › Article › peer-review

Open Access
File

27 Citations (Scopus)

21 Downloads (Pure)